News from egalet ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 23, 2015, 06:00 ET
Egalet Logo

Egalet to Host Conference Call and Webcast to Discuss First Quarter 2015 Financial Results on May 7, 2015

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 13, 2015, 06:00 ET
Egalet Logo.

Egalet Appoints Nicholas Nicolaides, Ph.D. and John Osborn to Board of Directors

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 07, 2015, 16:01 ET
Egalet Logo

Egalet Announces Closing of $60 Million Offering of Convertible Senior Notes Due 2020

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 01, 2015, 09:51 ET
Egalet Logo.

Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Mar 25, 2015, 06:00 ET
Egalet Logo

Egalet Provides Commercial Update on SPRIX® and OXAYDO™

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Mar 17, 2015, 06:00 ET
Egalet Logo.

Egalet Earns $10 Million Milestone Payment Triggered by Advancement of Shionogi's Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's Guardian™ Technology

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Mar 16, 2015, 06:00 ET
Egalet Logo.

Egalet Reports Full Year 2014 Financial Results

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported financial results for the year ended December 31, 2014. 2014 Financial...

Mar 11, 2015, 06:00 ET
Egalet Logo

Egalet Accelerates Development of Abuse-Deterrent Morphine Egalet-001 and Plans to File New Drug Application in the Fourth Quarter

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced plans to file a new drug application (NDA) by the end of 2015 for Egalet-001, an...

Mar 09, 2015, 09:33 ET
Egalet Logo

Egalet to Release 2014 Fourth Quarter and Year-End Financial Results on March 16, 2015 and to Host Conference Call and Webcast to Discuss Commercial Launch on March 25, 2015

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its fourth quarter and year ended December 31, 2014 financial results will...

Feb 02, 2015, 08:29 ET

Egalet to Present at Upcoming Conferences in February

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a specialty pharmaceutical company focused on developing and commercializing effective pain...

Nov 12, 2014, 06:00 ET
Egalet Logo.

Egalet Reports Third Quarter 2014 Financial Results and Provides Business Update

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the three months ended September 30,...

Oct 29, 2014, 08:30 ET

Egalet to Host Conference Call and Webcast to Discuss Third Quarter Financial Results on November 12, 2014

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its third quarter financial results will be released on Wednesday, November...

Aug 12, 2014, 06:00 ET
Egalet Logo.  (PRNewsFoto/Egalet Corporation)

Egalet Reports Second Quarter 2014 Financial Results and Provides Business Update

Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the three months ended June 30,...

Jul 29, 2014, 09:30 ET

Egalet to Host Conference Call and Webcast to Discuss Second Quarter Financial Results on August 12, 2014

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its second quarter financial results will be released on Tuesday, August 12,...

May 13, 2014, 07:00 ET

Egalet Reports First Quarter 2014 Financial Results and Provides Business Update

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the three months ended March 31,...

Apr 29, 2014, 08:00 ET
Egalet Logo.  (PRNewsFoto/Egalet Corporation)

Egalet to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 13, 2014

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its first quarter financial results will be released on Tuesday, May 13,...

Mar 26, 2014, 07:00 ET
Egalet Logo.  (PRNewsFoto/Egalet Corporation)

Egalet Reports Full Year 2013 Financial Results and Provides Business Update

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the year ended December 31,...

Mar 13, 2014, 08:00 ET
Egalet Logo.  (PRNewsFoto/Egalet Corporation)

Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 26, 2014

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its fourth quarter and year ended December 31, 2013 financial results will...

Feb 20, 2014, 08:00 ET
Egalet Logo.  (PRNewsFoto/Egalet Corporation)

Egalet Receives Fast Track Designation for Egalet-001 and Egalet-002 for Moderate to Severe Pain

Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status for...

Feb 19, 2014, 08:00 ET
Egalet Logo.  (PRNewsFoto/Egalet Corporation)

Egalet to Present at the Cowen and Company 34th Annual Health Care Conference on March 4

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that Bob Radie, president and chief executive officer, is scheduled to present...